Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eledon Pharmaceuticals, Inc. (TKAI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eledon Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1404281.
Total stock buying since 2014: $23,589,674.
Total stock sales since 2014: $5,680,476.
Total stock option exercises since 2014: $193,832.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 1,927,937 | $0 | 0 | $0 | 0 | $0 |
| 2023 | 1,978,932 | $0 | 0 | $0 | 0 | $0 |
| 2022 | 3,000 | $7,791 | 0 | $0 | 0 | $0 |
| 2021 | 9,000 | $57,830 | 0 | $0 | 0 | $0 |
| 2020 | 92,040 | $2,348,584 | 116,169 | $2,577,104 | 0 | $0 |
| 2019 | 1,292,408 | $4,006,464 | 29,651 | $58,018 | 0 | $0 |
| 2018 | 34,485 | $164,338 | 0 | $0 | 0 | $0 |
| 2017 | 80,080 | $799,997 | 0 | $0 | 0 | $0 |
| 2016 | 8,000 | $45,920 | 0 | $0 | 28,015 | $28,015 |
| 2015 | 3,000 | $33,750 | 200,808 | $2,835,521 | 71,064 | $165,817 |
| 2014 | 1,075,000 | $16,125,000 | 14,777 | $209,833 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-05 | 1,927,937 | $0 | 0 | $0 | 0 | $0 |
| 2023-05 | 1,978,932 | $0 | 0 | $0 | 0 | $0 |
| 2022-11 | 3,000 | $7,791 | 0 | $0 | 0 | $0 |
| 2021-12 | 2,000 | $8,960 | 0 | $0 | 0 | $0 |
| 2021-08 | 4,000 | $24,840 | 0 | $0 | 0 | $0 |
| 2021-06 | 3,000 | $24,030 | 0 | $0 | 0 | $0 |
| 2020-12 | 0 | $0 | 103,200 | $2,229,120 | 0 | $0 |
| 2020-10 | 92,040 | $2,348,584 | 12,969 | $347,984 | 0 | $0 |
| 2019-05 | 1,292,408 | $4,006,464 | 29,451 | $57,478 | 0 | $0 |
| 2019-04 | 0 | $0 | 200 | $540 | 0 | $0 |
| 2018-09 | 34,485 | $164,338 | 0 | $0 | 0 | $0 |
| 2017-05 | 80,080 | $799,997 | 0 | $0 | 0 | $0 |
| 2016-03 | 8,000 | $45,920 | 0 | $0 | 0 | $0 |
| 2016-01 | 0 | $0 | 0 | $0 | 28,015 | $28,015 |
| 2015-11 | 3,000 | $33,750 | 0 | $0 | 0 | $0 |
| 2015-09 | 0 | $0 | 20,326 | $278,392 | 13,500 | $56,565 |
| 2015-07 | 0 | $0 | 64,602 | $917,164 | 32,564 | $46,262 |
| 2015-06 | 0 | $0 | 59,914 | $842,196 | 25,000 | $62,990 |
| 2015-04 | 0 | $0 | 6,825 | $85,225 | 0 | $0 |
| 2015-03 | 0 | $0 | 49,141 | $712,544 | 0 | $0 |
| 2014-09 | 1,075,000 | $16,125,000 | 0 | $0 | 0 | $0 |
| 2014-06 | 0 | $0 | 14,777 | $209,833 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-09 | Lampert Mark N | Buy | 1,927,937 | .00 | 0 |
| 2023-05-05 | Lampert Mark N | Buy | 1,978,932 | .00 | 0 |
| 2022-11-23 | Perrin Steven (President) | Buy | 2,000 | 2.60 | 5,194 |
| 2021-12-20 | Gros David-alexandre C (Chief Executive Officer) | Buy | 2,000 | 4.48 | 8,960 |
| 2021-08-17 | Gros David-alexandre C (Chief Executive Officer) | Buy | 4,000 | 6.21 | 24,840 |
| 2021-06-09 | Gros David-alexandre C (Chief Executive Officer) | Buy | 3,000 | 8.01 | 24,030 |
| 2020-12-02 | Orbimed Israel Biofund Gp Limited Partnership | Sale | 103,200 | 21.60 | 2,229,120 |
| 2020-10-30 | Logos Global Management Lp | Buy | 92,040 | 25.52 | 2,348,584 |
| 2020-10-30 | Logos Global Management Lp | Sale | 12,969 | 26.83 | 347,984 |
| 2019-05-21 | Flesher Gregory J. (Chief Executive Officer) | Sale | 2,937 | 1.91 | 5,612 |
| 2019-05-21 | Turkel Catherine C. (President) | Sale | 1,914 | 1.91 | 3,657 |
| 2019-05-21 | Kuwahara Jon (See Remarks) | Sale | 1,058 | 1.91 | 2,021 |
| 2019-05-20 | Flesher Gregory J. (Chief Executive Officer) | Sale | 11,701 | 1.96 | 22,957 |
| 2019-05-20 | Turkel Catherine C. (President) | Sale | 7,623 | 1.96 | 14,956 |
| 2019-05-20 | Kuwahara Jon (See Remarks) | Sale | 4,218 | 1.96 | 8,275 |
| 2019-05-02 | Chimovits Erez | Buy | 646,204 | 3.10 | 2,003,232 |
| 2019-05-02 | Orbimed Israel Biofund Gp Limited Partnership | Buy | 646,204 | 3.10 | 2,003,232 |
| 2019-04-30 | Yook Paul | Sale | 200 | 2.70 | 540 |
| 2018-09-12 | Turkel Catherine C. (President) | Buy | 16,632 | 5.02 | 83,476 |
| 2018-09-11 | Turkel Catherine C. (President) | Buy | 17,048 | 4.56 | 77,670 |
| 2018-09-05 | Turkel Catherine C. (President) | Buy | 805 | 3.97 | 3,192 |
| 2017-05-10 | Flesher Gregory J. (Chief Executive Officer) | Buy | 58,959 | 9.99 | 589,000 |
| 2017-05-10 | Turkel Catherine C. (Chief Development Officer) | Buy | 11,111 | 9.99 | 110,998 |
| 2017-05-10 | Ocampo Christine (See Remarks) | Buy | 10,010 | 9.99 | 99,999 |
| 2016-03-15 | Buckley Stephen Jr. | Buy | 8,000 | 5.74 | 45,920 |
| 2016-01-08 | Morrison Jodie Pope (President and CEO) | Option Ex | 28,015 | 1.00 | 28,015 |
| 2015-11-11 | Buckley Stephen Jr. | Buy | 3,000 | 11.25 | 33,750 |
| 2015-09-21 | Mcbride John S. (Chief Operating Officer) | Sale | 13,500 | 14.01 | 189,135 |
| 2015-09-21 | Mcbride John S. (Chief Operating Officer) | Option Ex | 13,500 | 4.19 | 56,565 |
| 2015-09-08 | Kalowski Lee (Chief Financial Officer) | Sale | 4,668 | 13.13 | 61,290 |
| 2015-09-02 | Kalowski Lee (Chief Financial Officer) | Sale | 2,158 | 12.96 | 27,967 |
| 2015-07-29 | Morrison Jodie Pope (President and CEO) | Sale | 564 | 13.70 | 7,726 |
| 2015-07-29 | Morrison Jodie Pope (President and CEO) | Option Ex | 10,564 | 1.19 | 12,602 |
| 2015-07-28 | Morrison Jodie Pope (President and CEO) | Sale | 12,000 | 13.70 | 164,400 |
| 2015-07-28 | Morrison Jodie Pope (President and CEO) | Option Ex | 12,000 | 1.58 | 18,960 |
| 2015-07-22 | Morrison Jodie Pope (President and CEO) | Option Ex | 10,000 | 1.47 | 14,700 |
| 2015-07-15 | Novartis Ag (10% Owner) | Sale | 3,566 | 14.26 | 50,844 |
| 2015-07-14 | Novartis Ag (10% Owner) | Sale | 27,861 | 14.41 | 401,477 |
| 2015-07-13 | Novartis Ag (10% Owner) | Sale | 20,611 | 14.20 | 292,717 |
| 2015-06-29 | Morrison Jodie Pope (President and CEO) | Sale | 8,000 | 13.70 | 109,600 |
| 2015-06-29 | Morrison Jodie Pope (President and CEO) | Option Ex | 8,000 | 1.58 | 12,640 |
| 2015-06-26 | Morrison Jodie Pope (President and CEO) | Sale | 8,000 | 13.83 | 110,640 |
| 2015-06-26 | Morrison Jodie Pope (President and CEO) | Option Ex | 8,000 | 1.58 | 12,640 |
| 2015-06-24 | Mcbride John S. (Chief Operating Officer) | Sale | 300 | 14.20 | 4,260 |
| 2015-06-24 | Mcbride John S. (Chief Operating Officer) | Option Ex | 300 | 4.19 | 1,257 |
| 2015-06-23 | Mcbride John S. (Chief Operating Officer) | Sale | 6,700 | 14.00 | 93,800 |
| 2015-06-23 | Mcbride John S. (Chief Operating Officer) | Option Ex | 6,700 | 4.19 | 28,073 |
| 2015-06-22 | Mcbride John S. (Chief Operating Officer) | Sale | 2,000 | 14.02 | 28,040 |
| 2015-06-22 | Mcbride John S. (Chief Operating Officer) | Option Ex | 2,000 | 4.19 | 8,380 |
| 2015-06-16 | Novartis Ag (10% Owner) | Sale | 1,120 | 14.27 | 15,982 |
| 2015-06-12 | Novartis Ag (10% Owner) | Sale | 5,919 | 14.20 | 84,049 |
| 2015-06-11 | Novartis Ag (10% Owner) | Sale | 27,875 | 14.20 | 395,825 |
| 2015-04-16 | Kalowski Lee (Chief Financial Officer) | Sale | 4,567 | 13.00 | 59,371 |
| 2015-04-02 | Kalowski Lee (Chief Financial Officer) | Sale | 2,258 | 11.45 | 25,854 |
| 2015-03-19 | Novartis Ag (10% Owner) | Sale | 46,141 | 14.50 | 669,044 |
| 2015-03-18 | Novartis Ag (10% Owner) | Sale | 3,000 | 14.50 | 43,500 |
| 2014-09-22 | Apple Tree Partners Ii - Annex, L.p. (Director) | Buy | 237,500 | 15.00 | 3,562,500 |
| 2014-09-22 | Harrison Seth Loring (Director) | Buy | 362,500 | 15.00 | 5,437,500 |
| 2014-09-22 | Satter Muneer A (10% Owner) | Buy | 150,000 | 15.00 | 2,250,000 |
| 2014-09-22 | Novartis Ag (10% Owner) | Buy | 325,000 | 15.00 | 4,875,000 |
| 2014-06-15 | Novartis Ag (10% Owner) | Sale | 14,777 | 14.20 | 209,833 |
Insider trading activities including stock purchases, stock sales, and option exercises of TKAI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eledon Pharmaceuticals, Inc. (symbol TKAI, CIK number 1404281) see the Securities and Exchange Commission (SEC) website.